http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114432422-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
| filingDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114432422-B |
| titleOfInvention | Application of tripeptide in preparation of medicine for treating spermatogenesis dysfunction |
| abstract | The invention relates to the application of a tripeptide in the preparation of a medicine for treating spermatogenesis dysfunction, and belongs to the technical field of medicine. The present invention provides a tripeptide Met-Ser-Arg. Studies have found that the tripeptide Met-Ser-Arg can significantly increase the number of cell layers and spermatocytes in the seminiferous tubules of irradiated mice, and stimulate the irradiated mice. Proliferation of mouse spermatogonial stem cells, differentiating spermatogonia, pachytene spermatocytes, bitline spermatocytes, terminal spermatocytes, and spermatocytes, and significantly increased sperm motility in irradiated mice It has great application prospects in the prevention and/or treatment of radiation-induced spermatogenic dysfunction and radiation-induced sperm motility reduction. |
| priorityDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.